Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

AFRICA, INDIA: GSK and Aeras to Test Vaccine in Africa, India




 

Chicago Tribune (10.10.12)

In Africa and India, GlaxoSmithKline (GSK) and Aeras, a nonprofit biotechnology group, will work together to assess an experimental tuberculosis (TB) vaccine in “proof of concept” tests. The partners plan to start a mid-stage Phase IIb clinical study in Kenya, South Africa, and India in 2013, after successful initial tests with the GSK product, Aeras said on October 10. TB is spreading in spite of the widespread use of the currently available TB vaccine Bacille Calmette-Guerin (BCG), which prevents some forms of TB. BCG, however, does not prevent pulmonary TB, which accounts for the majority of infections and deaths. The new GSK-Aeras vaccine candidate is intended to be used together with BCG. Aeras and GSK will conduct the clinical trial in healthy adults aged 18 to 50 years old. Both partners will provide resources for the trial, which is scheduled to start in 2013, pending approvals from authorities.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in October 11, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.